Literature DB >> 22561303

Conduction and refractory disorders in the diabetic atrium.

Masaya Watanabe1, Hisashi Yokoshiki, Hirofumi Mitsuyama, Kazuya Mizukami, Taisuke Ono, Hiroyuki Tsutsui.   

Abstract

Diabetes mellitus (DM) is an independent risk of atrial fibrillation. However, its arrhythmogenic substrates remain unclear. This study sought to examine the precise propagation and the spatiotemporal dispersion of the action potential (AP) in the diabetic atrium. DM was induced by streptozotocin (65 mg/kg) in 8-wk-old male Wister rats. Optical mapping and histological analysis were performed in the right atrium (RA) from control (n = 26) and DM (n = 27) rats after 16 wk. Rate-dependent alterations of conduction velocity (CV) and its heterogeneity and the spatial distribution of AP were measured in RA using optical mapping. The duration of atrial tachyarrhythmia (AT) induced by rapid atrial stimulation was longer in DM (2.4 ± 0.6 vs. 0.9 ± 0.3 s, P < 0.05). CV was decreased, and its heterogeneity was greater in DM than control. Average action potential duration of 80% repolarization (APD(80)) at pacing cycle length (PCL) of 200 ms from four areas within the RA was prolonged (53 ± 2 vs. 40 ± 3 ms, P < 0.01), and the coefficient of variation of APD(80) was greater in DM than control (0.20 ± 0.02 vs. 0.15 ± 0.01%, P < 0.05). The ratio of APD(80) at PCL shorter than 200 ms to that at 200 ms was smaller (P < 0.001), and the incidence of APD alternans was higher in DM than control (100 vs. 0%, P < 0.001). Interstitial fibrosis was greater and connexin 40 expression was lower in DM than control. The remodeling of the diabetic atrium was characterized as follows: greater vulnerability to AT, increased conduction slowing and its heterogeneity, the prolongation of APD, the increase in spatial dispersion and frequency-dependent shortening of APD, and increased incidence of APD alternans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561303     DOI: 10.1152/ajpheart.00010.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  28 in total

Review 1.  Alternans in atria: Mechanisms and clinical relevance.

Authors:  Giedrius Kanaporis; Lothar A Blatter
Journal:  Medicina (Kaunas)       Date:  2017-06-07       Impact factor: 2.430

Review 2.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

3.  Reduced Na⁺ current density underlies impaired propagation in the diabetic rabbit ventricle.

Authors:  Catherine L Stables; Hassan Musa; Aditi Mitra; Sandesh Bhushal; Makarand Deo; Guadalupe Guerrero-Serna; Sergey Mironov; Manuel Zarzoso; Karen L Vikstrom; William Cawthorn; Sandeep V Pandit
Journal:  J Mol Cell Cardiol       Date:  2014-01-09       Impact factor: 5.000

Review 4.  Atrial Fibrillation and Metabolic Syndrome: Understanding the Connection.

Authors:  Prabhat Kumar; Anil K Gehi
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 5.  Role of diabetes in heart rhythm disorders.

Authors:  Buelent Koektuerk; Murat Aksoy; Marc Horlitz; Ilkay Bozdag-Turan; Ramazan Goekmen Turan
Journal:  World J Diabetes       Date:  2016-02-10

6.  Impaired left atrial strain in the presence of interatrial block in patients with type 2 diabetes mellitus.

Authors:  Mustafa Dogdus; Ferhat Dindas; Onur Akhan; Mustafa Yenercag; Arafat Yildirim; Ozge Ozcan Abacioglu; Salih Kilic
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-06       Impact factor: 2.357

7.  Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes.

Authors:  Iuliia Polina; Hailey J Jansen; Tiesong Li; Motahareh Moghtadaei; Loryn J Bohne; Yingjie Liu; Pooja Krishnaswamy; Emmanuel E Egom; Darrell D Belke; Sara A Rafferty; Martin Ezeani; Anne M Gillis; Robert A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-20       Impact factor: 11.205

Review 8.  Effect of antidiabetic drugs on the risk of atrial fibrillation: mechanistic insights from clinical evidence and translational studies.

Authors:  Ting-Wei Lee; Ting-I Lee; Yung-Kuo Lin; Yao-Chang Chen; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Cell Mol Life Sci       Date:  2020-09-23       Impact factor: 9.261

Review 9.  The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases.

Authors:  Yuxia Pan; Li Xu; Xinchun Yang; Mulei Chen; Yuanfeng Gao
Journal:  Heart Fail Rev       Date:  2021-03-25       Impact factor: 4.214

Review 10.  Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes.

Authors:  Mónica Gallego; Julián Zayas-Arrabal; Amaia Alquiza; Beatriz Apellaniz; Oscar Casis
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.